Compare Fidelity National Information Servcs Inc (FIS) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fidelity National Information Servcs Inc vs Immunovant Inc. Common Stock — how do they compare? Fidelity National Information Servcs Inc trades at $34.36 (market cap $17.44B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Fidelity National Information Servcs Inc is far larger — about 2.6× Immunovant Inc. Common Stock's market cap, and Fidelity National Information Servcs Inc pays a 5.2% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fidelity National Information Servcs Inc for 88 Days and Immunovant Inc. Common Stock for 0 Days on average.
| FIS | IMVT | |
|---|---|---|
Market Cap | $17.44B | $6.62B |
Volume | 6,437,765 | 1,131,364 |
Sector | Technology | Health |
52-Week High | $68.57 | $44.96 |
52-Week Low | $32.44 | $17.03 |
Typical Hold Time | 88 Days | 0 Days |
Enterprise Value | $37.95B | $5.72B |
Dividend Yield | 5.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIS trades at $34.34, up 2.75% today, with a bearish technical signal despite recent earnings beats in Q1 and Q2 2026. The company shows improving fundamentals with revenue growth from $10.7B in 2025 to projected $12.2B in 2026 and strong profitability metrics including 27.65% net income margin. Recent news highlights strategic wins in core banking modernization and embedded finance platforms.
The stock presents a compelling value opportunity with a low P/E of 5.2 and analyst consensus target of $47.54 (38% upside), though risks include significant debt load and volatile cash flow trends. Institutional sentiment remains positive with 57% buy ratings, but technical weakness near key support at $33 requires monitoring.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fidelity National Information Servcs Inc
Fidelity National Information Services' legacy operations provide core and payment processing services to banks, but its business has expanded over time. By acquiring Sungard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS now provides payment processing services for merchants and holds leading positions in the United States and United Kingdom. About a fourth of revenue is generated outside North America.
Read more on FIS →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
